REBIRTH Members

Hoppe, Nils

Hoppe, Nils, Prof. Dr. iur.

Work Group Leader

REBIRTH Unit Ethical and Legal Dimensions, CELLS - Centre for Ethics and Law in the Life Sciences Institute of Philosophy (LUH) and Institute for History, Ethics and Philosophy of Medicine (MHH)


Biosketch:

N. Hoppe (*1977), LL.B. (Europe, Nottingham Trent), Dr. iur. (Hannover) is a W3 professor of ‘Ethics and Law in the Life Sciences‘ and director of the Centre for Ethics and Law in the Life Sciences (CELLS) at LUH. He is Dean of Research at the Faculty of Humanities and Social Sciences and a member of various boards, including the UK Biobank Ethics and Governance Council and the DFG Senate Committee on Animal Experimentation. His research focuses on cross-border legal issues in life sciences, and on ethical, legal and social implications (ELSI) of regenerative medicine, human biomaterials, genetics and genomics, animal experimentation.

Biography / About

Date of Birth:June, 1977
Function:Associate (W2) Professor for Ethics and Law in the Life Sciences and Director of the Centre for Ethics and Law in the Life Sciences (CELS), Institute of Philosophy, LUH

Education:

1992 - 1996St Dunstan's College, London, UK
1996 - 2000Nottingham Law School (LL.B.(Europe) with Honours), Nottingham, UK
1998 - 1999Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany (Certificate in European Technology and Commercial Law, vollbefriedigend)
2002 - 2003Faculty of Law, Georg-August-Universität Göttingen, Germany
2004 - 2008Faculty of Law, LUH (Dr. iur., magna cum laude)
2015Chartered Institute of Arbitrators, London (Associate, international arbitration)
2016 - 2017BPP Law School, Bar Transfer

Academic appointments and Research posts:

2001 - 2003Staff scientist, legad advisor (Justitiar), University Medical Center Goettingen, Germany
2003 - 2004Staff Scientist, Department for Ethics and History of Medicine, Georg-August-Universität Göttingen
2004 - 2008Lecturer in English for Law, LUH
2008 - 2011Staff Scientist, Center for Philosophy and Ethics of Sciences and Institute for Legal Informatics, LUH
2011 - 2013Junior Professor for Regulation in the Life Sciences, Institute of Philosophy, LUH
2013 - 2016Professor for Regulation in the Life Sciences, Institute of Philosophy, LUH
Since 2016Professor for Ethics and Law in the Life Sciences, CELLS, LUH

Other professional activities:

Since 2013Member of the UK Biobank Ethics and Governance Council, London
Since 2014Member of the DFG Senate Committee on Animal Experimentation
Since 2015Member of the Ethics Committee, LUH
Since 2016Member of the Committee for Responsible Science, LUH
Since 2017Dean of Research, Faculty of Philosophy, LUH

Major research interests:

Ethical, Legal and Social Implications of:

  • Regenerative medicine
  • Human biomaterials
  • Genetics and genomics
  • Animal experementation

Furthermore

Door tenant, Coram Chambers London;
Fellow, Royal Society of Medicine;
Editor-in-Chief of "Ethics, Law and Economics of the Life Sciences", Nomos;
Editorial board member: European Journal of Health Law, Medical Law International.

Selected Publications:

  1. Hoppe NC. Privacy Laws and Biobanking in Germany. The Journal of Law, Medicine & Ethics. 2016. 44(1): 35-44.
  2. Kaye J, Briceño Moraia L, Curren L, Bell J, Mitchell C, Soini S, Hoppe NC, Øien M, Rial-Sebbag E. Consent for Biobanking: The Legal Frameworks of Countries in the BioSHaRE-EU Project. Biopreservation and Biobanking. 2016. 14(3): 195-200.
  3. Hoppe NC, Miola J. Innovation in medicine through degeneration in law? A critical perspective on the Medical Innovation Bill. Medical Law International. 2016. 14(4): 266-73.
  4. Briceño Moraia L, Kaye J, Tasse AM, Knoppers BM, Mitchell C, Soini S, Hoppe NC, Wallace SE, Øien M. A comparative analysis of the requirements for the use of data in biobanks based in Finland, Germany, the Netherlands, Nor-way and the United Kingdom. Medical Law International. 2015. 14(4): 187-212.
  5. Hoppe NC, Miola J. Medical Law and Medical Ethics. Cambridge: Cambridge University Press. 2014.
  6. Lenk C, Hoppe NC, Placebo-controlled trials: Is the EMA/ICH position consistent in itself and in accordance with the Declaration of Helsinki?. Medical Law International. 2014. 14(3): 115-32.
  7. Hoppe NC. Innovative tissue engineering and its regulation. In: Flear M, Hervey T, Murphy T, Farrell AM, editors. European Law and New Health Technologies. Oxford: Oxford University Press. 2013.
  8. Hoppe NC. The issue with tissue: why making human biomaterials available for research purposes is still controversial. Diagnostic Histopathology. 2013. 19(9): 315-21.
  9. Kaye J, Meslin EM, Knoppers BM, Juengst ET, Deschênes M, Cambon-Thomsen A, Chalmers D, De Vries J, Edwards K, Hoppe NC, Kent A, Adebamowo C, Marshall P, Kato K. ELSI 2.0: A New International Collaboratory for Genomics and Society Research. Science. 2012. 336(6082): 673-4
  10. 1Lenk C, Hoppe NC, Beier K, Wiesemann C, editors. Human Tissue Research – A European Perspective on the Ethical and Legal Challenges. Oxford: Oxford University Press. 2011.


[back to listing]
test
This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree